We have very little insider data for Pernix Therapeutics Holdings, Inc. so far: the most recent filing dates from 8 January 2019. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2017 · cache
21 of 21 declarations
Pernix Therapeutics Holdings, Inc. is a company focused on the development and commercialization of medications for the treatment of neurological and psychiatric disorders. It is listed on NASDAQ under the symbol PTX.